Skip to main content
Caplight Logo









Molecular Health

Molecular Health

Private
HeidelbergHealthcare & Life Scienceshttps://molecularhealth.com/

Last Round

VC Round

Nov 16, 2015

Total Funding Raised

$27M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Molecular Health is a healthcare technology company that operates a computational biomedicine platform to analyze molecular and clinical data for precision medicine.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Drug Discovery, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

precision medicineclinical decision supportbiomedical knowledge basedrug discoveryAI drug discoveryvariant annotationmedical AIhealthcare analyticsIVDRin vitro diagnostic regulationoncology softwareclinical trial matchingbiotech softwarehealthtechdigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Molecular Health Comparables

Compare Molecular Health with similar companies based on industry and business-model similarity.

Molecular Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SeqOne
81%
BC Platforms
81%
Genomenon Inc.
79%

Molecular Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 16, 2015
Private EquityNov 16, 2015

Key People

Founding team and executive leadership

Julian Payne

Chief Executive Officer

Executive Team

Molecular Health Investors

Notable investors and investment history

Molecular Health investors
InvestorRounds
dievini Hopp BioTech holdingVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 155% MoM, reaching 9.5K.

Molecular Health Filings

Explore SEC and related filing metadata, where available.

Molecular Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Molecular Health's valuation, stock price, and market status.

Is Molecular Health a public or private company?

Molecular Health is a private company.

What is the current stock price of Molecular Health?

Molecular Health is a private company with no public stock price. No recent secondary market data is available.

How much is Molecular Health worth (valuation)?

Valuation information for Molecular Health is not publicly available.

Can I buy Molecular Health stock?

Molecular Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Molecular Health's last funding round?

Molecular Health's most recent funding round was Private Equity on November 16, 2015.

Who are the main investors in Molecular Health?

Investor information for Molecular Health is not publicly disclosed.

Will Molecular Health IPO soon?

No public IPO plans have been announced for Molecular Health.

How can I track Molecular Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Molecular Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHeidelberg
Employee Range65
Year Founded2004
Last FundingNov 16, 2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?